Genome-wide expression analysis of wide-type and PirBTM MLL-AF9 LSCs
收藏官方服务：
资源简介：
Genome-wide expression analysis of wide-type and PirBTM MLL-AF9 LSCs
应用场景：
创建时间：
2012-03-08
相关数据集
The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells (expression data). Mus musculus
Using a mouse model of human MLL-AF9 leukemia, we identified the lysine-specific demethylase KDM1A (LSD1 or AOF2) as an essential regulator of leukemia stem cell (LSC) potential. KDM1A acts at genomic
NIAID Data Ecosystem40
Expression profiling with RNA-seq between mTORC1 high and low AML cells. Expression profiling with RNA-seq between mTORC1 high and low AML cells
We reported the expression profiling between mTORC1 high and low mouse AML cells with MLL-AF9 utilizing a novel fluorescent probe named mVenus-TOSI (TOr-Signal-Indicator). For this purpose, 3 mTOR hig
NIAID Data Ecosystem30
Enhancer remodeling drives MLL oncogene-dependent transcriptional dysregulation in leukemia stem cells [RNA-seq]
Acute myeloid leukemia (AML) with MLL gene rearrangement (MLLr) comprises a cellular hierarchy in which subpopulations of cells with distinct immunophenotypes serve as functional leukemia stem cells (
NIAID Data Ecosystem20
RNA-sequencing of WT and Asic3-null leukemia-initiating cells (LICs). Mus musculus
To tease apart the downstream signaling triggered by the Asic3-mediated ion current, RNA-sequencing analyses were conducted with WT and Asic3-null LICs. We found 199 genes were significantly up-regula
NIAID Data Ecosystem30
Leukemic initiation in Jam-C-deficient HSPC reveals AP-1/TNF- gene expression signature as a biomarker for AML. Leukemic initiation in Jam-C-deficient HSPC reveals AP-1/TNF- gene expression signature as a biomarker for AML
The leukemic stem cell score 17 (LSC-17) based on stemness gene expression signature is recognized as indicator of poor disease outcome in acute myeloid leukemia (AML). However, our understanding of t
NIAID Data Ecosystem30
